Jovan-Embiricos Morana (CIK 0001575745)

Latest company ownership

Shares held
26,502,857
Last filed at
Jun 7, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
3,220,387
Last filed at
Aug 4, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 2, 2022 Aug 4, 2022 Cullinan Therapeutics, Inc. 10% Owner Sell 20.0 -49,910 -1.10% ✗ $711.7K
Jun 24, 2022 Jun 28, 2022 Cullinan Therapeutics, Inc. 10% Owner Sell 30.0 -45,078 -0.99% ✗ $603.6K
Jun 21, 2022 Jun 23, 2022 Cullinan Therapeutics, Inc. 10% Owner Sell 17.5 -101,903 -2.25% ✗ $1.3M
May 12, 2022 May 16, 2022 Cullinan Therapeutics, Inc. 10% Owner Sell 17.5 -418,738 -8.46% ✗ $4M
Nov 10, 2021 Nov 15, 2021 Kalaris Therapeutics, Inc. Director Sell 57.5 -800 0.00% ✓ $19.8K
Nov 5, 2021 Nov 9, 2021 Kalaris Therapeutics, Inc. Director Sell 48.8 -12,196 -0.07% ✓ $302.5K
Oct 27, 2021 Oct 29, 2021 Kalaris Therapeutics, Inc. Director Sell 53.8 -2,200 -0.01% ✓ $54.5K
Oct 21, 2021 Oct 25, 2021 Kalaris Therapeutics, Inc. Director Sell 48.8 -13,592 -0.07% ✓ $337K
Jan 12, 2021 Jan 14, 2021 Cullinan Therapeutics, Inc. Director Buy 100.0 +200,000 31.28% ✗ $4.2M
Aug 3, 2020 Aug 6, 2020 Kalaris Therapeutics, Inc. Director Buy 100.0 +2,900,000 1046.15% ✗ $49.3M